Human kidney flavin-containing monooxygenases and their potential roles in cysteine S-conjugate metabolism and nephrotoxicity

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 1, 2003, Pages 185-191

  Krause, Renee J ^a   Lash, Lawrence H ^b   Elfarra, Adnan A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYSTEINE CONJUGATE; DIMETHYLANILINE MONOOXYGENASE; ENZYME ANTIBODY; S (1,2 DICHLOROVINYL)CYSTEINE; S ALLYLCYSTEINE;

ADULT; AGED; ARTICLE; CAUCASIAN; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; KIDNEY MICROSOME; LIVER MICROSOME; MALE; METABOLISM; NEGRO; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONTINENTAL POPULATION GROUPS; CYSTEINE; DNA, COMPLEMENTARY; FEMALE; HUMANS; ISOENZYMES; KIDNEY; KIDNEY DISEASES; MALE; MICROSOMES; MICROSOMES, LIVER; MIDDLE AGED; MONOAMINE OXIDASE; SEX CHARACTERISTICS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0037214432     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.042911     Document Type: Article

References (36)

1. Cummings BS and Lash LH (2000) Metabolism and toxicity of trichloroethylene and S-(1,2-dichlorovinyl)-L-cysteine in freshly isolated human proximal tubular cells. Toxicol Sci 53:458-466.
2. Dekant W, Lash LH, and Anders MW (1988) Fate of glutathione conjugates and bioactivation of cysteine S-conjugates by cysteine conjugate β-lyase, in Glutathione Conjugation. Mechanisms and Biological Significance (Sies H and Ketterer B eds) Academic Press, New York.
3. Dolphin CT, Cullingford TE, Shephard EA, Smith RL, and Phillips IR (1996) Differential developmental and tissue-specific regulation of expression of the genes encoding three members of the flavin-containing monooxygenase family of man, FMO1, FMO3 and FMO4. Eur J Biochem 235:683-689.
4. Dolphin CT, Beckett DT, Janmohamed A, Cullingford TE, Smith RL, Shephard EA, and Phillips IR (1998) The flavin-containing monooxygenase 2 gene (FMO2) of humans, but not of other primates, encodes a truncated, nonfunctional protein. J Biol Chem 273:30599-30607.
5. Duescher RJ, Latwon MP, Philpot RM, and Elfarra AA (1994) Flavin-containing monooxygenase (FMO)-dependent metabolism and evidence for FMO3 being the major FMO involved in methionine sulfoxidation in rabbit liver and kidney microsomes. J Biol Chem 269:17525-17530.
6. Elfarra AA (1997) Halogenated hydrocarbons, in Comprehensive Toxicology (Sipes IG, McQueen CA, Gandolfi AJ eds) vol 7, pp 601-616, Elsevier Science, Ltd., New York.
7. Hamman MA, Haehner-Daniels BD, Wrighton SA, Rettie AE, and Hall SD (2000) Stereoselective sulfoxidation of sulindac sulfide by flavin-containing monooxygenases. Comparison of human liver and kidney microsomes and mammalian enzymes. Biochem Pharmacol 60:7-17.
8. Hatano S, Jimenez A, and Wargovich MJ (1996) Chemopreventive effect of S-allyl cysteine and its relationship to the detoxification enzyme glutathione S-transferase. Carcinogenesis 17:1041-1044.
9. Hinchman CA and Ballatori N (1994) Glutathione conjugation and conversion to mercapturic acids can occur as an intrahepatic process. J Toxicol Environ Health 41:387-409.
10. Hines RN, Cashman JR, Philpot RM, Williams DE, and Ziegler DM (1994) The mammalian flavin-containing monooxygenases: Molecular characterization and regulation of expression. Toxicol Appl Pharmacol 125:1-6.
11. Ho SE, Ide N, and Lau BS (2001) S-Allyl cysteine reduces oxidant load in cells involved in the atherogenic process. Phytomed 8:39-46.
12. Kaye CM, Clapp JJ, and Young L (1972) The metabolic formation of mercapturic acids from allyl halides. Xenobiotica 2:129-139.
13. Koukouritaki SB, Simpson P, Yeung CK, Rettie AE, and Hines RN (2002) Human hepatic flavin-containing monooxygenase 1 (FMO1) and 3 (FMO3) developmental expression. Ped Res 51:236-243.
14. Krause RJ, Glocke SC, and Elfarra AA (2002) Sulfoxides as urinary metabolites of S-allyl-L-cysteine in rats: Evidence for the involvement of flavin-containing mono-oxygenases. Drug Metab Dispos 30:1137-1142.
15. Krause RJ, Ripp SL, Suasen PJ, Overby LH, Philpot RM, and Elfarra AA (1996) Characterization of the methionine S-oxidase activity of rat liver and kidney microsomes: Immunochemical and kinetic evidence for FMO3 being the major catalyst. Arch Biochem Biophys 333:109-116.
16. Lash LH, Hunei SE, and Putt DA (2001) Apoptosis, necrosis and cell proliferation induced by S-(1,2-dichlorovinyl)-L-cysteine in primary cultures of human proximal tubular cells. Toxicol Appl Pharmacol 177:1-16.
17. Lash LH, Putt DA, Abbas R, Brashear WT, Abbas R, Parker JC, and Fisher JW (1999) Identification of S-(1,2-dichlorovinyl)glutathione in the blood of human volunteers exposed to trichloroethylene. J Toxicol Environ Health 56:1-21.
18. Lash LH, Quian W, Putt DA, Jacobs K, Elfarra AA, Krause RJ, and Parker JC (1998) Glutathione conjugation of trichloroethylene in rats and mice: Sex-, species-, and tissue-dependent differences. Drug Metab Dispos 26:12-19.
19. Lash LH, Sausen PJ, Duescher RJ, Cooley AJ, and Elfarra AA (1994) Roles of cysteine conjugate β-lyase and S-oxidase in nephrotoxicity: Studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide. J Pharmacol Exp Therap 269:374-383.
20. Luo Z and Hines RN (2001) Regulation of flavin-containing monooxygenase 1 expression by ying yang 1 and hepatic nuclear factors 1 and 4. Mol Pharmacol 60:1421-1430.
21. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
22. Overby LH, Buckpitt AR, Lawton MP, Atta-Asafo-Adjei E, Schulze J, and Philpot RM (1995) Characterization of flavin-containing monooxygenase 5 (FMO5) cloned from human and guinea pig: Evidence that the unique catalytic properties of FMO5 are not confined to the rabbit ortholog. Arch Biochem Biophys 317:275-284.
23. Overby LH, Carver GC, and Philpot RM (1997) Quantitation and kinetic properties of hepatic microsomal and recombinant flavin-containing monooxygenases 3 and 5 from humans. Chem-Biol Interact 106:29-45.
24. Pike MG, Mays DC, Macomber DW, and Lipsky JJ (2001) Metabolism of a disulfiram metabolite, S-methyl-N,N-diethyldithiocarbamate, by flavin monooxygenase in human renal microsomes. Drug Metab Dispos 29:127-132.
25. Pinto JT, Qiao CH, Xing J, Rivlin RS, Protomastro ML, Weissler M, Tao Y, Thaler H, and Heston WDW (1997) Effects of garlic thio allyl derivatives on growth, glutathione concentration and polyamine formation of human prostate carcinoma cells in culture. Am J Clin Nutr 66:398-405.
26. Ripp SL, Itagaki K, Philpot RM, and Elfarra AA (1999a) Species and sex differences in expression of flavin-containing monooxygenase form 3 in liver and kidney microsomes. Drug Metab Dispos 27:46-52.
27. Ripp SL, Itagaki K, Philpot RM, and Elfarra AA (1999b) Methionine S-oxidation in human and rabbit liver microsomes: Evidence for a high-affinity methionine S-oxidase activity that is distinct from flavin-containing monooxygenase 3. Arch Biochem Biophys 367:322-332.
28. Ripp SL, Overby LH, Philpot RM, and Elfarra AA (1997) Oxidation of cysteine S-conjugates by rabbit liver microsomes and cDNA-expressed flavin-containing monooxygenases: Studies with S-(1,2-dichlorovinyl)-L-cysteine, S-(1,2,2-trichlorovinyl)-L-cysteine, S-allyl-L-cysteine and S-benzyl-L-cysteine. Mol Pharmacol 51:507-515.
29. Sausen PJ, Duescher RJ, and Elfarra AA (1993) Further characterization and purification of the flavin-dependent S-benzyl-L-cysteine S-oxidase activities of rat liver and kidney microsomes. Mol Pharmacol 43:388-396.
30. Sausen PJ and Elfarra AA (1990) Cysteine conjugate S-oxidase. J Biol Chem 265: 6139-6145.
31. Sausen PJ and Elfarra AA (1991) Reactivity of cysteine S-conjugates sulfoxides: Formation of S-[1-chloro-2-(S-glutathionyl)vinyl]-L-cysteine sulfoxide by the reaction of S-(1,2-dichlorovinyl)-L-cysteine sulfoxide with glutathione. Chem Res Toxicol 4:655-660.
32. Takeyama H, Hoon DSB, Saxton RE, Morton DL, and Irie RF (1993) Growth inhibition and modulation of cell markers of melanoma by S-allyl cysteine. Oncology 50:63-69.
33. Treacy EP, Akerman B, Chow LML, Youil R, Bibeau C, Lin J, Bruce G, Knight M, Danks DM, Cashman JR, and Forrest SM (1998) Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication. Hum Mol Genet 7:839-845.
34. Whetstine JR, Yueh M-F, Hopp KA, McCarver DG, Williams DE, Park C-S, Kang JH, Cha Y-N, Dolphin CT, Shephard EA, et al. (2000) Ethnic differences in human flavin-containing monooxygenase 2 (FMO2) polymorphisms: Detection of expressed protein in African Americans. Toxicol Appl Pharmacol 168:216-224.
35. Yeung CK, Lang DH, Thummel KE, and Rettie AE (2000) Immunoquantitation of FMO1 in human liver, kidney and intestine. Drug Metab Dispos 28:1107-1111.
36. Ziegler DM (1993) Recent studies on the structure and function of multisubstrate flavin-containing monooxygenases. Annu Rev Pharmacol Toxicol 33:179-199.